Jorge Dorta-Duque
Psychiatry · Orlando, FLNPI 1124053699
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,812 and has fallen 60.4% since, to $718 in 2025.
Across 153 payments — averaging $50.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Johnson & Johnson$705
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$678
- Neuronetics, Inc.$557
- AbbVie$511
- plus $3K from 14 others
What the payments were for
- Travel & lodging$2133%
- Food & beverage$7,51997%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 29 | $1,189 |
| Teva Pharmaceuticals USA, Inc. | 19 | $1,018 |
| Johnson & Johnson | 16 | $705 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $678 |
| Neuronetics, Inc. | 2 | $557 |
| AbbVie(2 entities) | 12 | $511 |
| Axsome Therapeutics, Inc. | 9 | $510 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $468 |
| Sunovion Pharmaceuticals Inc. | 7 | $412 |
| Otsuka America Pharmaceutical, Inc. | 14 | $399 |
| Neurocrine Biosciences, Inc. | 8 | $318 |
| Tris Pharma Inc | 5 | $307 |
| Indivior Inc. | 7 | $149 |
| E.r. Squibb & Sons, L.L.C. | 2 | $138 |
| Boehringer Ingelheim | 1 | $125 |
| Gilead | 1 | $124 |
| Braeburn Inc. | 4 | $71 |
| USWM, LLC | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,485
- AUSTEDO$725
- CAPLYTA$596
- NEUROSTAR TMS THERAPY SYSTEM$557
- ARISTADA$500
- Auvelity$358
- LATUDA$351
- INVEGA SUSTENNA$342
- INVEGA TRINZA$342
- Dyanavel XR$247
- VRAYLAR$236
- INGREZZA$227
- SPRAVATO$203
- REJOYN$150
- ARISTADA INITIO$125
- Epclusa$124
- COBENFY$119
- REXULTI$116
- ABILIFY MAINTENA$112
How this compares
$7,735 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Orlando
- Ramon MartinezOrlando$354K
- David MedinaOrlando$199K
- Carlos RuizOrlando$104K
- Morteza NadjafiOrlando$58K
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.